QT interval: heart-rate correction, normal and prolonged QTc, causes of long and short QT and torsade risk.
The QT interval is measured from the start of the QRS complex to the end of the T wave. It covers the whole electrical cycle of the ventricles: depolarisation and repolarisation. The QT shortens as heart rate rises, so it is corrected for heart rate (QTc). An abnormally long or short QT increases the risk of dangerous ventricular arrhythmias, especially torsade de pointes, and of sudden cardiac death.
ECGRepolarisationArrhythmia risk
Prolonged QTc≥ 450 ms men, ≥ 460 ms women
Short QTc≤ 390 ms
High torsade riskQTc > 500 ms
LQTS diagnosis (ESC 2022)QTc ≥ 480 ms on repeated ECGs
Figure 1. The QT interval (highlighted) includes the QRS complex, the ST segment and the T wave.
Bazett's formula is the most widely used but overcorrects at fast heart rates and undercorrects at slow ones. Fridericia's and Framingham's formulas are more accurate for monitoring QT during drug treatment.
Figure 2. QTc zones in adults. The upper limit of normal is 450 ms for men and 460 ms for women (AHA/ACCF/HRS 2009).
Causes of a long QT
Medicines: antiarrhythmics (sotalol, amiodarone, quinidine), macrolide and fluoroquinolone antibiotics, antipsychotics, some antidepressants, methadone, ondansetron, antifungals
Electrolytes: low potassium, magnesium or calcium
Congenital long QT syndrome (ion channel gene variants)
A short QT can be caused by hypercalcaemia, digoxin, hyperkalaemia or acidosis, and rarely by congenital short QT syndrome.
Figure 3. Left: normal QT. Right: prolonged QT, in which the T wave ends much later.
Seek emergency care
for fainting, seizures or palpitations in a person with a long QT, especially after starting a new medicine, with vomiting or diarrhoea (potassium loss) or during exercise or emotional stress.
References
Rautaharju PM, Surawicz B, Gettes LS. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval. Circulation. 2009;119(10):e241–e250. doi:10.1161/CIRCULATIONAHA.108.191096
Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997–4126. doi:10.1093/eurheartj/ehac262
Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010;121(8):1047–1060. doi:10.1161/CIRCULATIONAHA.109.192704
Vandenberk B, Vandael E, Robyns T, et al. Which QT correction formulae to use for QT monitoring? J Am Heart Assoc. 2016;5(6):e003264. doi:10.1161/JAHA.116.003264
This article is for general information and does not replace a consultation with a doctor. ECG findings must be interpreted by a physician together with symptoms and other tests.